Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
Harnik S, Abitbol CM, Haj Natour O, Yavzori M, Fudim E, Picard O, Naftali T, Broide E, Hirsch A, Selinger L, Shachar E, Yablecovitch D, Albshesh A, Coscas D, Kopylov U, Eliakim R, Ben-Horin S, Ungar B.
Harnik S, et al. Among authors: shachar e.
J Crohns Colitis. 2024 Mar 1;18(3):341-348. doi: 10.1093/ecco-jcc/jjad156.
J Crohns Colitis. 2024.
PMID: 37691574